Abvc Biopharma (ABVC) Other Working Capital Changes (2019 - 2026)

Abvc Biopharma (ABVC) has reported Other Working Capital Changes for 1 consecutive years, with -$1.0 the latest figure, recorded in Q4 2023.

• For the quarter ending Q2 2026, Other Working Capital Changes fell 45.17% year-over-year to -$107622.0; the trailing twelve-month figure through Jun 2026 stood at -$497638.0 (down 236.98% YoY), and the FY2025 full-year result was -$474479.0, down 180.93% from the prior year.
• Other Working Capital Changes eased to -$107622.0 in Q2 2026 per ABVC's latest filing, from -$96599.0 in the prior quarter.
• Across five years, Other Working Capital Changes topped out at $203621.0 in Q1 2023 and bottomed at -$204341.0 in Q2 2023.
• Historically, Other Working Capital Changes has averaged -$70693.0 across 4 years, with a median of -$100182.0 in 2024.
• The sharpest annual moves came in 2024 and 2025: Other Working Capital Changes jumped 50.56% in 2024, then slumped 248.8% in 2025.
• Over 4 years, Other Working Capital Changes stood at -$204341.0 in 2023, then surged by 164.95% to $132728.0 in 2024, then plunged by 248.8% to -$197498.0 in 2025, then jumped by 45.51% to -$107622.0 in 2026.
• According to Business Quant data, Other Working Capital Changes over the past three periods registered -$107622.0, -$96599.0, and -$197498.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.